ArticleCureus2021
Spectrum of Chest Dual-Energy Computed Tomography Findings in COVID Patients in North India.
Article in Cureus, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
- Pulmonary infarcts in COVID-19.Clinical imaging · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose To study the spectrum of chest dual-energy computed tomography (DECT) imaging findings in severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) or COVID-19 infected Indian patients and classify them on the basis of the Radiological Society of North America CT classification. Method A total of 110 reverse transcription-polymerase chain reaction (RT-PCR)-positive patients (subjects) in which noncontrast chest DECT was done in our COVID-19 care center (CCC) were enrolled in this study. The prevalence of various abnormalities of lung parenchyma due to SARS-COV-2 and their distribution with extent was recorded. Various types of lung parenchyma abnormalities due to COVID-19 were evaluated in all patients. Data were analyzed and various prevalent abnormalities were calculated as a percentage for each type. All the cases were also sorted into four major groups on the basis of the Radiological Society of North America CT classification of COVID patients. Result Among the total 110 patients that were enrolled in this study, 80 (72.7%) were males and 30 (27.3%) were females with a mean age of 40.5 ± 7 years (range 24-84). Out of this, we observed that 59 (53.6%) cases had abnormalities of lung parenchyma and were designated as DECT positive, whereas 51 (46.3%) cases had completely normal DECT. Only 14 (12.7%) of the patients (cases) presented with dyspnoea, 10 (9%) had hyperpnoea, whereas 12 (10.8%) had other associated comorbidities. Among the patients having abnormal DECT findings, multilobar (86%), bilateral lung field involvement (72.8%) with the ascendancy of peripheral and posterior distribution was most commonly noted. With respect to the different types of opacities noted in various patients, we found that ground-glass opacity (GGO) was the common abnormality found in almost all cases for the greatest part. Pure GGO was reported in 16 (28%), GGO admixed with a crazy-paving pattern were elicited in 17 (28.8%) and GGO mixed with consolidation was noted in 25 (42.3%) cases. Thirty-eight (64.4%) cases were having peri-lesional or intra-lesional segments or involving a small segment enlargement of the pulmonary vessel. Among the cases showing DECT positivity, the typical pattern on the basis of the Radiological Society of North America (RSNA) classification was noted in 71.2% of cases, whereas the atypical pattern was found in 1.2% percent of cases and the intermediate type was depicted in 25.4% percent of cases. Forty-six point three percent (46.3%) of the total cases that were enrolled in the study were grouped as the no pneumonia category. Conclusion The result of this study proved that the maximum number of RT-PCR-positive COVID-19 patients had mild symptoms and few comorbidities with normal chest DECT and fell under the no pneumonia category of the RSNA CT classification of COVID patients. However, out of the remaining patients, the majority of patients had GGO on DECT as a typical finding mixed with other patterns in a bilateral distribution and peripheral predominance. A preponderance of patients presented with the typical appearance of pneumonia followed by an intermediate type.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.